Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Targeted Therapies in Lung Cancer Patient Forum 2017 – It’s a Wrap!
dbrock
Image
On Saturday, September 16, 2017, patients, caregivers, family members and friends joined GRACE in Cleveland at the Taussig Cancer Center for a full day of discussion on Targeted Therapies in Lung Cancer. We are thrilled that people joined us for this amazing and informative day. Huge thanks to all of the faculty who spent their Saturday in Cleveland with our community, and thanks also to those organizations who sponsored this event - Astra Zeneca, Takeda, Boehringer Ingelheim, Ignyta, Novartis, Genentech, Caris, and Guardant Health.
We started the day out with a warm welcome from our Forum Chair - Dr. Nathan Pennell. For the full agenda, faculty list, presentations, and videos from the webcast, please visit the 'webcast details' page, available via this link.
The morning sessions continued:
The Many Faces of Progression
Dr. Nathan Pennell, Cleveland Clinic Cancer Center
The Role of Local Therapy
Dr. Shirish Gadgeel, Michigan Medicine, University of Michigan
Biopsies & Re-biopsies
Dr. Karen Reckamp, City of Hope Comprehensive Cancer Center
The Question of Clinical Trials
Dr. Alice Shaw, Massachusetts General Hospital
The Crossroads:
Local Therapy, Chemo, Targeted Therapy, or Immunotherapy?
Panel Discussion with Drs. Pennell, Gadgeel, Reckamp, and Shaw, and patients John Cherol (EGFR), Matt Hiznay (ALK), and Sara Whitlock (RET). Moderator: Dr. H. (Jack) West
Lunch was an opportunity to have further discussion with the faculty. Cleveland Clinic Cancer Center graciously allowed us to set up lunch on the 1st floor in their beautiful new facility.
After lunch the breakout discussions continued:
Dr. Alice Shaw, Dr. Shirish Gadgeel, and Matt Hiznay, ALK patient
Dr. Nathan Pennell, Dr. H. (Jack) West, and John Cherol, EGFR patient
Dr. Karen Reckamp, Dr. Vamsidhar Velcheti, and Sara Whitlock, RET patient
The day concluded with the afternoon general session:
Managing the Cost of Cancer Care
Dr. James P. Stevenson, Cleveland Clinic Cancer Center
Patient to Patient Mentoring
Kathryn Sefcek, MHA, 4th Angel Mentoring Program
Caveat Emptor: Assessing Cancer Information from Sources of Varying Quality
Dr. H. (Jack) West, Swedish Cancer Institute & Founder of cancerGRACE, and Janet Freeman-Daily, ROS1 patient, #LCSM Twitter Chat co- moderator, Cure Today contributor, blogger
Please click here to visit the Targeted Therapies in Lung Cancer Webcast page for viewing the videos in full! (Please note, we will be editing the videos to cut them down - they are in raw format at this time).
Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.